S.M.A.R.T. Our inspiration came right from the source. Feeling is believing. S.M.A.R.T. Flex Vascular Stent System. LinkedIn page
|
|
|
- April Carr
- 6 years ago
- Views:
Transcription
1 to receive our latest news and key activities. S.M.A.R.T. Flex Vascular System Our inspiration came right from the source. S.M.A.R.T. Flex Vascular System Feeling is believing. LinkedIn page Follow us on CORDIS EMEA
2 S.M.A.R.T. Flex Vascular System EXPERIENCE THE LATEST INNOVATION IN SELF-EXPANDING STENTS. The S.M.A.R.T. Flex Vascular System was inspired by the native vessel and designed to overcome the constant biomechanical challenges that stents face. It builds on the strength of our proven S.M.A.R.T. and is engineered with outstanding flexibility, making it the only fully connected yet highly flexible self-expanding stent. It s a difference you can feel in the stent and in your procedures. Helical strut bands provide radial force
3 Built upon the PALMAZ heritage with a tissue-to-metal ratio of 80% to 90% and high radial strength Excellent fracture resistance due to helical strut bands and diameter-specific design Complete portfolio of sizes for treating both longer and small-diameter lesions Placement accuracy is supported by low deployment forces and fully connected architecture Outstanding flexibility as a result of multiple flex bridges Superior longitudinal stability from fully connected design and scaffolding 1 Flex bridges provide complete scaffolding with flexibility
4 S.M.A.R.T. Flex Vascular System DELIVERS OUTSTANDING DURABILITY AND RADIAL FORCE. Superior fracture resistance 1 No fractures observed in 10-million-cycle in-vitro testing protocol (axial compression cycle 0 14%) FRACTURE RESISTANCE Mean Cycle Count (K) to First Fracture 1 10,000 1, Cordis S.M.A.R.T. Flex Cook Zilver * Bard Life Covidien EverFlex+ Abbott Absolute Higher cycle counts for higher fracture resistance. * Two of the first four stents fractured.
5 High radial force Ability to resist compression and maximize luminal diameter, enabling increased blood flow 1 RADIAL FORCE (N/cm) Cordis S.M.A.R.T. Cordis S.M.A.R.T. Flex Bard Life Covidien EverFlex+ Cook Zilver Abbott Absolute Higher value for better radial force. INCREASED RADIAL FORCE MAXIMIZES LUMINAL GAIN Greater radial force = Larger lumen = More flow Flow = 16πV Flow = 25πV Flow = 36πV r = 4 mm r = 5 mm r = 6 mm S.M.A.R.T. Flex Vascular System is designed to maintain luminal gain Vessel 1 mm gain in radius = 56% greater flow 2 mm gain in radius = 125% greater flow
6 S.M.A.R.T. Flex Vascular System EASY TO PLACE. STRONG ON STABILITY. Deployment confidence Fully connected design is intended to minimize stretching at deployment, facilitating accurate placement Lower chronic force at deployment contributes to easy, accurate stent placement 1 Distal and proximal radiopaque markers help facilitate accurate placement Simple delivery system for easy deployment Radiopaque markers CHRONIC OUTWARD FORCE (N) Cordis S.M.A.R.T. Flex Cook Zilver Abbott Absolute Covidien EverFlex+ Bard Life Lower value for lower COF. UNIQUE DESIGN PROVIDES UNIFORM SCAFFOLDING AND SMALL CELL SIZE Cordis S.M.A.R.T. Flex ev3 Protégé EverFlex Abbott Absolute Bard Life Cook Zilver 32 Struts/16 Bridges* 32 Struts/4 Bridges 12 Struts/3 Bridges 36 Struts/4 Bridges 24 Struts/4 Bridges * 32 struts/16 bridges for 7 mm and 8 mm diameter stents. 26 struts/13 bridges for 5 mm and 6 mm diameter stents.
7 Greater longitudinal stability and fracture resistance Exceptional stability can help to reduce stent stretching during deployment, thereby increasing placement accuracy and achieving the intended radial force and scaffolding Small cell size and uniform coverage ensure optimal scaffolding to minimize lesion prolapse 1 LONGITUDINAL STABILITY Force Needed to Stretch 50% Lengthwise (N) Cordis S.M.A.R.T. Flex Cook Zilver Covidien EverFlex+ Bard Life Abbott Absolute Higher value for higher longitudinal stability. Complete portfolio of sizes Gives you the flexibility to treat both longer and small-diameter lesions in superficial femoral artery and proximal popliteal artery S.M.A.R.T. FLEX STENT SIZES 5 8 mm diameters mm lengths
8 FEELING IS BELIEVING. Experience the latest innovation in self-expanding stents. You ll feel the difference. Superior fracture resistance High radial force Greater longitudinal stability Deployment confidence Noticeably flexible Complete portfolio of sizes Want to feel the difference? Call your Cordis representative. The S.M.A.R.T. Flex Vascular System is more than a single product; it s a total portfolio commitment. In addition, it s an example of Cordis providing leadership you can count on through innovations that reflect outstanding engineering, performance, and an accelerated commitment to excellence. 1. The data provided in this brochure are based on mechanical and in-vitro testings performed by Cordis Corporation (data on file, Cordis). Those data are intended to provide technical information based on in-vitro testings for which results cannot be transposed to clinical interpretation.
9 S.M.A.R.T. Flex Vascular System Our inspiration came right from the source. Experience the latest innovation in self-expanding stents. S.M.A.R.T. Flex Vascular System Feeling is believing.
10 S.M.A.R.T. Flex Vascular System Product Description Type: Fully connected yet flexible stent design Material: Nitinol, with tantalum markers on stent ends Maximum Guidewire: 0.035" Lengths: mm Sheath Compatibility: 6F Diameters: 5-8 mm ( diameter should be mm greater than vessel diameter) Delivery System Working Lengths: 80 cm (S suffix) and 120 cm (M suffix) Ordering Information Product Code Delivery System 80 cm Usable 120 cm Usable Recommended Recommended Sheath Guidewire Length Length Diameter (mm) Length (mm) Lumen Size (mm) Introducer Size Acceptance SF05030SV SF05030MV " SF05040SV SF05040MV " SF05060SV SF05060MV " SF05080SV SF05080MV " SF05100SV SF05100MV " SF05120SV SF05120MV " SF05150SV SF05150MV " SF05200SV SF05200MV " SF06030SV SF06030MV " SF06040SV SF06040MV " SF06060SV SF06060MV " SF06080SV SF06080MV " SF06100SV SF06100MV " SF06120SV SF06120MV " SF06150SV SF06150MV " SF06200SV SF06200MV " SF07030SV SF07030MV " SF07040SV SF07040MV " SF07060SV SF07060MV " SF07080SV SF07080MV " SF07100SV SF07100MV " SF07120SV SF07120MV " SF07150SV SF07150MV " SF07200SV SF07200MV " SF08030SV SF08030MV " SF08040SV SF08040MV " SF08060SV SF08060MV " SF08080SV SF08080MV " SF08100SV SF08100MV " SF08120SV SF08120MV " SF08150SV SF08150MV " Important Information: Prior to use, refer to the Instructions for Use supplied with these devices for indications, contraindications, side effects, suggested procedure, warnings, and precautions. As part of the Cordis policy of continuous product development, we reserve the right to change product specifications without prior notification. For healthcare professionals only Cardinal Health. All Rights Reserved. CORDIS, the Cordis LOGO, PALMAZ and S.M.A.R.T. FLEX are trademarks of Cardinal Health and may be registered in the US and/or in other countries. All other marks are the property of their respective owners. EU /17
Unique technologies for the endoluminal treatment of complex PAD lesions
Unique technologies for the endoluminal treatment of complex PAD lesions Athanasios D Giannoukas, MD, MSc, PhD, FEBVS Professor of Vascular Surgery, Faculty of Medicine, School of Health Sciences, University
Conformability without Compromise
Conformability without Compromise THE STANDARD IN Conformability AND Designed for flexibility and conformability in tortuous anatomy. Optimized aortic wall apposition in angulated arch anatomy without
Conformability without Compromise
Conformability without Compromise THE STANDARD IN Conformability AND Designed for flexibility and conformability in tortuous anatomy. Optimized aortic wall apposition in angulated arch anatomy without
The evolution of stent design for chronic iliac vein obstruction
The evolution of stent design for chronic iliac vein obstruction Stephen Black Consultant Vascular Surgeon Clinical Lead for Venous and Lymphoedema Surgery Guys and St Thomas Hospital London They Not
PER F ORM ANC E b y d e s i g n. Pioneering TEVAR Therapy, Time and Time Again. CONFORMABLE
PER F ORM ANC E b y d e s i g n Pioneering TEVAR Therapy, Time and Time Again. CONFORMABLE T H O R A C I C E N D O P R O S T H E S I S Time-Tested Success For more than 16 years, the GORE TAG Device has
Peripheral Vascular Stents for the Lower Extremity
Peripheral Vascular Stents for the Lower Extremity Current and Future Players GDME1008FPR / Published April 2013 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 6 1.2 List of Figures...
STUDY OF STENT DEFORMATION AND STRESS DEVELOPED AT DIFFERENT STENT DEPLOYMENT PRESSURES
STUDY OF STENT DEFORMATION AND STRESS DEVELOPED AT DIFFERENT STENT DEPLOYMENT PRESSURES KRISTI BASU PRANAB GHOSH DR. ABHIJIT CHANDA SCHOOL OF BIOSCIENCE AND ENGINEERING JADAVPUR UNIVERSITY KOLKATA: 700032
Company Update. 28 May REVA Medical, Inc.
Company Update 28 May 2015 6 Recent Milestones Q2 through Q4 2014 Developed Fantom (to offer the desired advancements for a second generation product) November 2014 Completed $25 million financing (warrants
In-Service Presentation
In-Service Presentation 12016 2016 Boston Boston Scientific. Scientific. Corporation or its or Affiliates. its Affiliates. All rights All rights reserved. reserved. PI-379301-AA EU MAR2016 Agenda WallFlex
TOBA II and TOBA III Clinical Programme Updates
TOBA II and TOBA III Clinical Programme Updates Michael K. W. Lichtenberg MD, FESC Vascular Center Arnsberg, Germany Conflict of Interest - Disclosure Within the past 12 months, I or my spouse/partner
Steerable Guide Wires Precision With Every Turn
Steerable Guide Wires Precision With Every Turn The Wholey * and Covidien families of guide wires combine the right amount of support and flexibility along with 1:1 torque control to provide precision
Conformability without Compromise. Now FDA APPROVED
Conformability without Compromise Now FDA APPROVED THE STANDARD IN Conformability AND Designed for flexibility and conformability in tortuous anatomy. Optimized aortic wall apposition in angulated arch
ACCESS OPTIONS FOR PATIENTS WITH VENOUS OUTFLOW INSUFFICIENCY SYSTEM MERIT IS COMMITTED TO DIALYSIS ACCESS
ACCESS OPTIONS FOR PATIENTS WITH VENOUS OUTFLOW INSUFFICIENCY SYSTEM MERIT IS COMMITTED TO DIALYSIS ACCESS SYSTEM When end stage renal disease patients are catheter-dependent or are approaching catheter
REVA s Bioresorbable Scaffold Program Update. Alexandre Abizaid, MD, PhD, FACC Instituto Dante Pazzanese de Cardiologia Sao Paulo, Brazil
REVA s Bioresorbable Scaffold Program Update Alexandre Abizaid, MD, PhD, FACC Instituto Dante Pazzanese de Cardiologia Sao Paulo, Brazil REVA s Technology Transition to the Fantom Scaffold 2011: ReZolve
Bioresorbable Scaffold Program Update. Alexandre Abizaid, MD, PhD, FACC Instituto Dante Pazzanese de Cardiologia Sao Paulo, Brazil
Bioresorbable Scaffold Program Update Alexandre Abizaid, MD, PhD, FACC Instituto Dante Pazzanese de Cardiologia Sao Paulo, Brazil Disclosure Statement of Financial Interest Within the past 12 months, I
Protect the Neck. Lieven Maene, MD. Marc Bosiers Koen Deloose Joren Callaert. Patrick Peeters Jürgen Verbist. Lieven Maene Roel Beelen.
A.Z. Sint-Blasius, Dendermonde Marc Bosiers Koen Deloose Joren Callaert Imelda Hospital, Bonheiden Protect the Neck Patrick Peeters Jürgen Verbist OLV Hospital, Aalst Lieven Maene Roel Beelen R.Z. Heilig
V. Riambau and G. Mestres Vascular Surgery Division. Cardiovascular Institute Hospital Clinic. University of Barcelona
V. Riambau and G. Mestres Vascular Surgery Division. Cardiovascular Institute Hospital Clinic. University of Barcelona Consultant/Advisor Bolton Medical Cordis Bard Medtronic Aptus Lombard Medical ivascular
TREAT SMARTER. ACHIEVE MORE. When Treating Thrombus
TREAT SMARTER. ACHIEVE MORE. When Treating Thrombus Treat Smarter When you want fast, safe, predictable results EKOS Ultrasound Accelerated Thrombolysis Unlocks The Clot Without Ultrasonic Energy With
The Next Generation of Stents for the Lower Extremity: What s on the Horizon?
The Next Generation of Stents for the Lower Extremity: What s on the Horizon? PNEC 2017 Pacific Northwest Vascular Conference Thursday, May 25, 2017 Seattle, WA Brian DeRubertis, MD, FACS Associate Professor
You struggle to get into the fenestration: try a steerable guiding
You struggle to get into the fenestration: try a steerable guiding G Pratesi, MD Vascular Surgery University of Rome Tor Vergata Disclosure Giovanni Pratesi, M.D. I have the following potential conflicts
Silicone Mock Vessels and Anatomies Leading the world in silicone vasculature
Silicone Mock Vessels and Anatomies Leading the world in silicone vasculature Medical Device Testing & Equipment Simulation Platforms Silicone Vessels Silicone Vasculature from BDC Labs: A Legacy of Expertise
Yukon Choice 4 DES Translumina - Allows natural healing
Coronary Stent System for Drug Application Translumina - Allows natural healing Allows natural healing Clinical history of the Yukon Stent Excellent clinical results with the Rapamycin Yukon Stent Dose-finding
VASCULAR ACCESS PRELUDE SHEATH INTRODUCERS. Merit Medical s Innovative Family of Vascular Access Products A GREAT INTRODUCTION
VASCULAR ACCESS PRELUDE SHEATH INTRODUCERS Merit Medical s Innovative Family of Vascular Access Products A GREAT INTRODUCTION THE PRELUDE FAMILY OF SHEATH INTRODUCERS A comprehensive product line offering
Beyond Tried. True. GuideLiner V3 Catheter Guide Extension Catheter With Half-Pipe Technology
Beyond Tried. True. GuideLiner V3 Catheter Guide Extension Catheter With Half-Pipe Technology Beyond Tried. True. In 2009, the GuideLiner Catheter revolutionized the concept of guide extension, creating
Stent-based anastomotic coupler
Stent-based anastomotic coupler Design Team Nick Cote, Ryan Myers Matthew Ouellette, Jessica Patel David Schecter Design Advisor Prof. Jeffrey Ruberti Email: J.Ruberti@neu.edu Abstract Microvascular anastomosis
NEW PERSPECTIVES ON CHALLENGING AAA NECKS. And why graft design matters in treating Reverse Taper Necks. Supplement to. Sponsored by Endologix, Inc.
Supplement to Sponsored by Endologix, Inc. July 2015 NEW PERSPECTIVES ON CHALLENGING AAA NECKS And why graft design matters in treating Reverse Taper Necks Strong by design, in every direction. Durable
The Importance of Vessel Preparation
The Importance of Vessel Preparation and How To Do It Ralf Langhoff, MD Vascular Center Sankt Gertrauden Berlin Sankt Gertrauden Hospital Charité, CC11 Academic Teaching Hospitals Charité Berlin Caution:
Clinical evaluation of the swirling flow stent: the MIMICS experience
Clinical evaluation of the swirling flow stent: the MIMICS experience Prof. Thomas Zeller Department Angiology University Heart-Center Freiburg - Bad Krozingen Bad Krozingen, Germany Faculty Disclosure
SYNERGYTM. Everolimus-Eluting Platinum Chromium Coronary Stent System
SYNERGYTM EverolimusEluting Platinum Chromium Coronary Stent System Bioabsorbable R E D E F I N E d INTRODUCING THE SYNERGY TM EverolimusEluting Stent System featuring the innovative Synchrony TM Bioabsorbable
ARROW EDGE. Antegrade-tunneled chronic hemodialysis catheter
ARROW EDGE Antegrade-tunneled chronic hemodialysis catheter ARROW EDGE HEMODIALYSIS CATHETERIZATION SET CONTENTS: 1 Catheter: 15 Fr. 1 Arrow SmartSeal Hemostatic Peelable Dialysis Sheath: 16 Fr. 1 Spring
Proven leadership, smart innovation, customer success B E N C H M A R K I N H E A LT H C A R E I T.
T H E N E W Proven leadership, smart innovation, customer success B E N C H M A R K I N H E A LT H C A R E I T. Radiology Cardiology Enterprise Workflow Vendor Neutral Archive Cloud- Based Services Vue
Comfort your patient deserves. Strength you demand.
POLYSITE LOW PROFILE HYBRID PORTS Comfort your patient deserves. Strength you demand. We never settle because you never settle. Throughout our 35-year history, clinicians and patients have benefited from
Tyrocore: a proprietary polymer uniquely designed for vascular scaffolds
Tyrocore: a proprietary polymer uniquely designed for vascular scaffolds PD Dr. med Gregor Leibundgut Medizinische Universitätsklinik Kantonsspital Baselland Liestal, Switzerland 1 Potential conflicts
Dr. Alexandre Abizaid Instituto Dante Pazzanese de Cardiologia Sao Paulo, Brazil
FANTOM II: Six Month Clinical and Angiographic Results With a Radiopaque Desaminotyrosine Polycarbonate Based Sirolimus Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease
POLYSITE Low Profile Hybrid Ports. Comfort your patient deserves. Strength you demand.
POLYSITE Low Profile Hybrid Ports Comfort your patient deserves. Strength you demand. The comfort your patient deserves. POLYSITE Hybrid Ports Port combines lightweight plastic body for comfort and a strong
Symposium Biotronik High-Tech DRug Eluting Absorbable Metal Stent: dreaming the future! Didier Tchétché. Clinique Pasteur.
Symposium Biotronik High-Tech 2014 DRug Eluting Absorbable Metal Stent: dreaming the future! Didier Tchétché Clinique Pasteur Toulouse Key characteristics of absorbable scaffold materials Material PLLA
Bioresorbable Stent Implantation for Tibial Disease
Bioresorbable Stent Implantation for Tibial Disease Leipzig Interventional Course January 24-27, 2017 Leipzig, Germany Brian DeRubertis, MD, FACS Associate Professor of Surgery Division of Vascular & Endovascular
TRUFILL DCS ORBIT Detachable Coil System
ORBIT Conforming to Your Complex Needs Excellent Conformability and Concentric Filling for Outstanding Packing Density ORBIT Full range of Mini Complex and new Tight Distal Loop Technology coils Our Complex
YUKON DES. PEARL surface. Drug Eluting Stent System. Coronary Stent System for individual drug coating application. Stent coating machine
YUKON DES PEARL surface Drug Eluting Stent System Coronary Stent System for individual drug coating application Stent coating machine Free choice of drug Individual dosage No polymer coating Sterile coating
Merit Medical s Innovative Family. of Vascular Access Products. A Great Introduction
Merit Medical s Innovative Family of Vascular Access Products A Great Introduction Sheath Introducers The Prelude family of sheath introducers is a comprehensive product line offering excellent transitions,
ISO INTERNATIONAL STANDARD. Cardiovascular implants Endovascular devices Part 2: Vascular stents
INTERNATIONAL STANDARD ISO 25539-2 First edition 2008-09-01 Cardiovascular implants Endovascular devices Part 2: Vascular stents Implants cardiovasculaires Dispositifs endovasculaires Partie 2: Endoprothèses
Innovating to Create Value through New Perspectives and Synthesis
Feature Article Innovating to Create Value through New Perspectives and Synthesis With the corporate mission of Contributing to Society through Healthcare, the Terumo Group has brought valuable innovation
Ultrasound. It understands your everyday. Philips Affiniti 30 ultrasound system for women s health care
Ultrasound Affiniti 30 It understands your everyday Philips Affiniti 30 ultrasound system for women s health care Designed for balance You need to go above and beyond for your patients in less time, with
Zenith Alpha System, Designed for Easy and Durable repairs. Prof. Elixène JEAN-BAPTISTE (Nice)
Zenith Alpha System, Designed for Easy and Durable repairs Prof. Elixène JEAN-BAPTISTE (Nice) Aortic Disease Can Progress AFTER Repair Resulting in: Stent migration Endoleaks Sac enlargement Secondary
Virtual scaffolding and radial strength testing of stents
Virtual scaffolding and radial strength testing of stents M. De Beule, P. Mortier, G. De Santis, M. Conti, P. Segers, P. Verdonck, and B. Verhegghe biommeda - IBiTech, Ghent University, Belgium Abstract:
Scan. Smart. ACUSON NX2 Series. siemens.com/nx2
Scan Smart. ACUSON NX2 Series Scan Smart. Siemens Healthineers designs ultrasound solutions with purpose to deliver the advanced performance you expect from your investments through thoughtful solutions
EkoSonic MACH4 Endovascular Device Instructions for Use
EkoSonic MACH4 Endovascular Device Instructions for Use Indications for Use The EkoSonic Endovascular System is indicated for the: Ultrasound facilitated, controlled and selective infusion of physician-specified
Dr. Alexandre Abizaid Instituto Dante Pazzanese de Cardiologia Sao Paulo, Brazil. On behalf of the FANTOM II investigators
FANTOM II: Six-Month Clinical and Angiographic Results With a Radiopaque Desaminotyrosine Polycarbonate-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease
Case No COMP/M MEDTRONIC/ COVIDIEN
EN Case No COMP/M.7326 - MEDTRONIC/ COVIDIEN Only the English text is available and authentic. REGULATION (EC) No 139/2004 MERGER PROCEDURE Article 6(1)(b) in conjunction with Art 6(2) Date: 28/11/2014
A survey of stent designs
Min Invas Ther & Allied Technol 2002: 11(4) 137 147 A survey of stent designs D. Stoeckel 1, C. Bonsignore 1 and S. Duda 2 1 Nitinol Devices and Components, Fremont, CA USA 2 Dept of Diagnostic Radiology,
Interventional Cardiology
Interventional Cardiology APR Medtech OUR COMPANY APR Medtech is a specialist independent medical technology company providing high quality medical devices and support services to the NHS and private healthcare
Novel BioResorbable Vascular Platforms from India
DEEP DIVE SESSION: Lower limb interventions (part II) Femoropopliteal, drug-eluting devices, and new technologies Time 11:55am to 12:01pm Novel BioResorbable Vascular Platforms from India Dr. Vimal Someshwar
Young-Guk Ko, M.D. Severance Cardiovascular Hospital, Yonsei University Health System,
Young-Guk Ko, M.D., First EVAR Endograft in Human 1991 Annals of Vascular Surgery Dr. Juan Carlos Parodi, Surgeon Dr. Julio Palmaz, Radiologist Parodi-Palmaz endograft: Dacron + modified Palmaz stents
Technical solutions, and clinical utility of CO2 angiography. Ulf Teichgräber, MD, MBA Department of Radiology University Hospital Jena
Technical solutions, and clinical utility of CO2 angiography Ulf Teichgräber, MD, MBA Department of Radiology University Hospital Jena Disclosure Speaker name: Ulf Teichgräber, MD, MBA Potential conflicts
Vascular. Making Best Use of Trinias Applications for Lower Extremity Interventional Procedures. 1. Introduction
Vascular Making Best Use of Trinias Applications for Lower Extremity Interventional Procedures Yasuhiro Takahashi, M.D. Department of Cardiology, The Fraternity Memorial Hospital Yasuhiro Takahashi 1.
Study of Stent Deformation and Stress Developed at Different Stent Deployment Pressures
Study of Stent Deformation and Stress Developed at Different Stent Deployment Pressures Kristi Basu 1, Pranab Ghosh 1, Abhijit Chanda 1 1 School of Bio Science and Engineering, Jadavpur University, Kolkata-
ISO Cardiovascular implants Endovascular devices Part 2: Vascular stents Part 2: Vascular stent
INTERNATIONAL STANDARD ISO 25539-2 Second edition 2012-12-01 Cardiovascular implants Endovascular devices Part 2: Vascular stents Part 2: Vascular stent Implants cardiovasculaires Dispositifs endovasculaires
Nitinol for Vascular Stent Applications: Microstructure and Mechanical Properties
Nitinol for Vascular Stent Applications: Microstructure and Mechanical Properties A.D.Zervaki 1, H. Kamoutsi 1, G.N.Haidemenopoulos 1 and A.E.Giannakopoulos 2 1 Laboratory of Materials, Dept. of Mechanical
For personal use only
Presentations at CRT Conference San Diego, California and Sydney, Australia (Tuesday, 24 February 2015, AEDT) REVA Medical, Inc. (ASX: RVA) ( REVA or the Company ) is pleased to announce that Dr. Alexandre
Extending quality care to more people. Brivo CT315
GE Healthcare Extending quality care to more people. Brivo CT315 Big impact. Improving the quality of healthcare around the world is a goal we all share. But this can be a daunting challenge, with patients
(12) United States Patent (10) Patent No.: US 6,863,685 B2
USOO6863685B2 (12) United States Patent (10) Patent No.: Davila et al. (45) Date of Patent: Mar. 8, 2005 (54) RADIOPACITY INTRALUMINAL MEDICAL 5,632,771 A 5/1997 Boatman DEVICE 5,725,572 A 3/1998 Lam 5,741,327
Endovascular Device Testing A Survey of Requirements for Product Validation
MET A4 1p Endovascular Device Testing Info Sheet-02.qxp_MET A4 1p Endovascular Device Testing Info Sheet.qxp 05/04/2016 09:58 Page 1 Endovascular Device Testing A Survey of Requirements for Product Validation
RePlay Hemostasis Clip
RePlay Hemostasis Clip Instructions for use. Read carefully prior to use. Caution: Federal (U.S.A.) Law restricts this device to sale by or on the order of a physician. Diversatek Healthcare Corporate
BREAKING BOUNDARIES WITH ICE
IcePearl 2.1 CX L Needle IceFORCE 2.1 CX L Needle 23cm Length for Deep Tumours IceSphere 1.5 S Needle Short Shaft for Superficial Lesions IcePearl 2.1 CX Needle IceFORCE 2.1 CX Needle Large Ice, Smaller
Optimisation of angioplasty workflow for CO2-angiography in patients with kidney impairment
Optimisation of angioplasty workflow for CO2-angiography in patients with kidney impairment Disclosure Speaker name: Ulf Teichgräber, MD, MBA Potential conflicts of interest related to the presentation:
Interventional Cardiology Advisory Group Meeting held 17 February (minutes for web publishing)
Interventional Cardiology Advisory Group Meeting held 17 February 2017 (minutes for web publishing) In consideration of the upcoming request for proposals for permanent coronary drug eluting stents (DES)
EkoSonic Endovascular System
EkoSonic Endovascular System Nursing In-Service EKOS Corporation is a BTG International group company US-EKO-1800192 Forward-looking statement This presentation and information communicated verbally to
Approaching Commercialization
Approaching Commercialization October 31, 2016 1 Important Notice Not an Offer for Securities This presentation does not constitute an offer, invitation, solicitation or recommendation with respect to
GE Healthcare. Vivid S6. Cardiovascular ultrasound system
GE Healthcare Vivid S6 Cardiovascular ultrasound system Taking care of everyone. Strong performance and innovative miniaturization make the Vivid S6 a highly desirable system for a variety of clinical
Fantom: A Radio-Opaque Stent-Like BRS With Improved Expansion Characteristics
DIDACTIC SESSION: BIORESORBABLE VASCULAR SCAFFOLDS, PART 1 - DEVICES AND EMERGING DATA Session III. Next Generation Scaffolds Part 1: Design Iterations, Data, and Clinical Development Colorado Convention
Evolution of Intravascular Technology for Coronary Artery Disease Treatment
Evolution of Intravascular Technology for Coronary Artery Disease Treatment Yunbing Wang Nadine Ding, James Oberhauser Thierry Glauser, Xiao Ma, Derek Mortisen Bioabsorbable Vascular Solutions (BVS) Abbott
FREQUENTLY ASKED QUESTIONS
FREQUENTLY ASKED QUESTIONS P E R F O R M A N C E t h r o u g h i n n o v a t i o n 2 Table of Contents Technology What is the GORE Hybrid Vascular Graft?...............................................................
intervention embosphere embogold quadrasphere bearing nspva
Embolics intervention embosphere embogold quadrasphere bearing nspva Merit Medical brings efficiency, safety, and value to embolotherapy with a comprehensive line of Clinically PROVEN products designed
Contains Nonbinding Recommendations Draft - Not for Implementation
Reprinted from FDA s website by EAS Consulting Group, LLC Select Updates for Non-Clinical Engineering Tests and Recommended Labeling for Intravascular Stents and Associated Delivery Systems Draft Guidance
UNIQUE CHALLENGES DEMAND MEANINGFUL INNOVATIONS. Specialty stapling and advanced energy solutions for thoracic surgeons
UNIQUE CHALLENGES DEMAND MEANINGFUL INNOVATIONS. Specialty stapling and advanced energy solutions for thoracic surgeons OUR JOB IS TO MAKE YOURS EASIER. TO HELP YOU SAVE MORE LIVES. Having the right tools
Mechanics of Laser Cu Stent Grafts
21 st International Conference ENGINEERING MECHANICS 2015 Svratka, Czech Republic, May 11 14, 2015 Full Text Paper #191, pp. 25 30 Mechanics of Laser Cu Stent Grafts!t"pán Major 1,a, Vladimír Kocour 1,b
Azur Peripheral Coil System Helical HydroCoil Embolization System (Detachable) Instructions for Use
Azur Peripheral Coil System Helical HydroCoil Embolization System (Detachable) Instructions for Use DEVICE DESCRIPTION The Detachable Azur Peripheral Coil System (Azur system) consists of a coil implant
I K Number I Trade Name Manufacturer K ADMIRAL XTREME' PTA Invatec Innovative Catheter. 510(k) Summary (c) FEB i1 PREDICATE DEVICE
510(k) Summary 807.92(c) FEB 2 3 20i1 SPONSOR 807.92(a)(1) Company Name: Natec Medical Ltd. Company Address Maeva Centre Building - Ebene Business Park Redluit, Mauritius Telephone: +230 466 3054 Fax:
New Fully Absorbable Patch Based Large Hole Vascular Closure Device Arne Schwindt, MD
New Fully Absorbable Patch Based Large Hole Vascular Closure Device Arne Schwindt, MD St. Franziskus-Hospital, Münster Disclosure Speaker name: Arne Schwindt, MD I have the following potential conflicts
Magnetic Resonance Imaging (MRI) Safety for Boston Scientific Products. 1. WALLSTENT Iliac Endoprosthesis with Unistep Plus Delivery System
Magnetic Resonance Imaging (MRI) Safety for Boston Scientific Products Table of Contents 1. WALLSTENT Iliac Endoprosthesis with Unistep Plus Delivery System.1 2. WALLSTENT RP Endoprosthesis (Transhepatic
For personal use only
REVA MEDICAL PRESENTS KEY DATA SETS AT THE TRANSCATHETER CARDIOVASCULAR THERAPEUTICS CONFERENCE 2018 Sydney, Australia and San Diego, California (Monday, 24 September 2018 - AEST) REVA Medical, Inc. (ASX:
Solving Healthcare Challenges. Increasing patient safety, reducing errors and improving efficiencies with Intermec Healthcare Solutions.
Solving Healthcare Challenges Increasing patient safety, reducing errors and improving efficiencies with Intermec Healthcare Solutions. You re under unprecedented pressure. As a healthcare provider, you
A New Endoprosthesis With Sensing Capability
A New Endoprosthesis With Sensing Capability Isa C.T. Santos, Alexandra Sepúlveda, Luís Rocha & João Manuel R.S. Tavares ICABB 2010 October 14-16 Venice, Italy Outline Aneurysm Treatment options Thoracic
Decide, guide, treat and confirm: The Philips Volcano CLI solution
Decide, guide, treat and confirm: The Philips Volcano CLI solution Trademarks are the property of Koninklijke Philips N.V. or their respective owners Critical Limb Ischemia Affects the Lives of Many Patients
EUROPEAN COMMISSION. Brussels, 04.IV.2006 C(2006)1189 final. State aid N 639/2005 Ireland Abbott Vascular Devices Ireland. Sir, 1.
EUROPEAN COMMISSION Brussels, 04.IV.2006 C(2006)1189 final Subject: State aid N 639/2005 Ireland Abbott Vascular Devices Ireland Sir, 1. PROCEDURE (1) The Irish authorities notified the abovementioned
The Leader in the Science of Heart Valves and Hemodynamic Monitoring
The Leader in the Science of Heart Valves and Hemodynamic Monitoring Cautionary Statement Presentations and comments made today by the management of Edwards Lifesciences Corporation will include forward
Bioabsorbable metal stents: properties, modeling and open questions
Biomedical Engineering Bioabsorbable metal stents: properties, modeling and open questions Palma Tartaglione Supervisor: Prof. Ferdinando Auricchio Co-supervisor : Ing. Mauro Ferraro December 16, 2014
Built for strength and security.
Built for strength and security. Instinct ENDOSCOPIC HEMOCLIP MEDICAL Trust your instincts. During critical hemostatic clipping procedures, you need an endoscopic hemoclip with features you can rely on.
January 13, Texas Medical Technologies, Inc. Consultant Smith Associates 1468 Harwell Avenue Crofton, Maryland 21114
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service January 13, 2016 Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 Texas
Lombard Medical, Inc. (NASDAQ:EVAR) June 2016
Lombard Medical, Inc. (NASDAQ:EVAR) June 2016 Safe Harbor This presentation contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995, as amended.
Peripheral Arterial Disease
Peripheral Arterial Disease Registry Assessment of Peripheral Interventional Devices (RAPID) Launched June 5, 2015 Goal Standardize core data elements that could serve as a global case report form for
Bioabsorbable Stents. The Ideal Scaffold properties and kinetics. Jonathan Hill King s College Hospital King s Health Partners
Bioabsorbable Stents The Ideal Scaffold properties and kinetics Jonathan Hill King s College Hospital King s Health Partners Transient Biodegradable Scaffold Building a skyscraper in Hong Kong with bamboo
Bioreactors in tissue engineering
Bioreactors in tissue engineering S. Swaminathan Director Centre for Nanotechnology & Advanced Biomaterials School of Chemical & Biotechnology SASTRA University Thanjavur 613 401 Tamil Nadu Joint Initiative
CapSure Permanent Fixation System
CapSure Permanent Fixation System Permanent Fixation Redefined Advancing the Fixation Experience Recipient of 2015 SLS Innovations of the Year recognition. SOFT TISSUE REPAIR Right Procedure. Right Product.
Whitepaper: Precision Micro-Braiding for Implantable Devices
Whitepaper: Precision Micro-Braiding for Implantable Devices Keys to Design Success When Contemplating Medical Device Braids By: Robert Kiefer and Keith Smith Braided textile structures are among the most
NEUROVASCULAR CARDIAC RHYTHM MANAGEMENT ELECTROPHYSIOLOGY INTERVENTIONAL BRONCHOSCOPY GYNECOLOGY UROLOGY
Boston Scientific ELEMENT Drug-Eluting Stent Program Keith Dawkins MD FRCP FACC FSCAI Chief Medical Officer Senior Vice President Boston Scientific Corporation BSC Core Business Coronary Stents 23% CRM
Modular branched endograft system for aortic aneurysm repair: evaluation in a human cadaver circulation model
Modular branched endograft system for aortic aneurysm repair: evaluation in a human cadaver circulation model Vascular and Endovascular Surgery. 2007 41: 126 9 M.A.M. Linsen A.W.F. Vos J. Diks J.A. Rauwerda
Acoustic Pulse Thrombolysis Treatment
Acoustic Pulse Thrombolysis Treatment In-Service Presentation Acoustic Pulse Thrombolysis treatment is a minimally invasive system for accelerating thrombus dissolution. FORWARD-LOOKING STATEMENT This
Accuant. Global Partner Program.
Accuant Global Partner Program www.acuantcorp.com 2015 Acuant, Inc. All Rights Reserved. Acuant, the Acuant logo, idscan, MedicScan, SnapShell and ScanShell are trademarks or registered trademarks of Acuant,
China-EU Competition Week: Abbott's Acquisition of St. Jude Medical
China-EU Competition Week: Abbott's Acquisition of St. Jude Medical Anti-monopoly Bureau, MOFCOM Tang Yu March 2017 Part I: basic information of the case Part II: definition of relevant markets and competitive